tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market

Verve Therapeutics (VERV) Technical Analysis

368 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
4Neutral
9Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Verve Therapeutics’s (VERV) Moving Averages Convergence Divergence (MACD) indicator is -0.24, suggesting Verve Therapeutics is a Buy.
Verve Therapeutics’s (VERV) 20-Day exponential moving average is 13.63, while Verve Therapeutics’s (VERV) share price is $13.28, making it a Sell.
Verve Therapeutics’s (VERV) 50-Day exponential moving average is 13.55, while Verve Therapeutics’s (VERV) share price is $13.28, making it a Sell.

Verve Therapeutics (VERV) Pivot Points

Apr 23, 2024, 11:56 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.22
12.44
12.81
13.03
13.40
13.62
13.99
Fibonacci
12.44
12.66
12.80
13.03
13.25
13.39
13.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verve Therapeutics (VERV) Moving Averages

Apr 23, 2024, 11:56 AM
Period
Simple
Exponential
MA5
13.08Buy
13.17Buy
MA10
13.21Buy
13.35Sell
MA20
14.03Sell
13.63Sell
MA50
13.25Buy
13.55Sell
MA100
13.23Buy
13.46Sell
MA200
14.24Sell
14.32Sell
Verve Therapeutics’s (VERV) 10-Day exponential moving average is 13.35, while Verve Therapeutics’s (VERV) share price is $13.28, making it a Sell.
Verve Therapeutics’s (VERV) 100-Day exponential moving average is 13.46, while Verve Therapeutics’s (VERV) share price is $13.28, making it a Sell.
Verve Therapeutics’s (VERV) stock price is $13.28 and Verve Therapeutics’s (VERV) 50-day simple moving average is 13.25, creating a Buy signal.
Verve Therapeutics’s (VERV) stock price is $13.28 and Verve Therapeutics’s (VERV) 100-day simple moving average is 13.23, creating a Buy signal.
Verve Therapeutics’s (VERV) stock price is $13.28 and Verve Therapeutics’s (VERV) 200-day simple moving average is 14.24, creating a Sell signal.

Verve Therapeutics (VERV) Technical Indicators

Apr 23, 2024, 11:56 AM
Name
Value
Implied Action
RSI (14)
46.29
Neutral
STOCH (9,6)
26.66
Neutral
STOCHRSI (14)
13.76
Buy
MACD (12,26)
-0.24
Buy
ADX (14)
18.61
Buy
Williams %R
-78.28
Buy
CCI (14)
-59.59
Neutral
ATR (14)
0.89
-
Ultimate Oscillator
44.85
Neutral
ROC
-11.23
Sell
Verve Therapeutics’s (VERV) Relative Strength Index (RSI) is 46.29, creating a Neutral signal.
Verve Therapeutics’s (VERV) Trend Strength Indicator (ADX) is 18.61, creating a Buy signal.
Verve Therapeutics’s (VERV) Commodity Channel Index (CCI) is -59.59, creating a Neutral signal.
Verve Therapeutics’s (VERV) Price Rate of Change (ROC) is -11.23, creating a Sell signal.

FAQ

Is VERV a Buy, Hold, or Sell?
Based on VERV’s technical indicators, VERV is a Hold.
    What is VERV’s RSI (14)?
    VERV’s RSI (14) is 46.29, which suggests VERV is a Neutral.
      What is VERV’s MACD?
      VERV’s MACD is -0.24, which suggests VERV is a Buy.
        What is VERV’s 5-day moving average?
        VERV’s 5-day moving average is 13.08, which suggests VERV is a Buy.
          What is VERV’s 20-day moving average?
          VERV 20-day moving average is 14.03, which suggests VERV is a Sell.
            What is VERV’s 50-day moving average?
            VERV’s 50-day moving average is 13.25, which suggests VERV is a Buy.
              What is VERV’s 200-day moving average?
              VERV’s 200-day moving average is 14.24, which suggests VERV is a Sell.
                What is VERV’s Williams % R (14)?
                VERV’s Williams % R (14) is -78.28, which suggests VERV is a Buy.
                  What is VERV’s CCI (14)?
                  VERV’s CCI (14) is -59.59, which suggests VERV is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis